Extended levobunolol release from Eudragit nanoparticle-laden contact lenses for glaucoma therapy
Abstract Background Majorly, the reason for the permanent loss of vision is glaucoma. But the currently available common treatment methodologies such as eye drops have various disadvantages like patient incompliance due to repeated administration and poor (1-5%) bioavailability leading to poor effic...
Furkejuvvon:
Váldodahkkit: | Navneet Kumar (Dahkki), Rohan Aggarwal (Dahkki), Meenakshi K. Chauhan (Dahkki) |
---|---|
Materiálatiipa: | Girji |
Almmustuhtton: |
SpringerOpen,
2020-11-01T00:00:00Z.
|
Fáttát: | |
Liŋkkat: | Connect to this object online. |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid
-
Novel Eudragit® -based polymeric nanoparticles for sustained release of simvastatin
Dahkki: Deborah Fernandes Rodrigues, et al.
Almmustuhtton: (2020) -
Thermally-Responsive Loading and Release of Elastin-Like Polypeptides from Contact Lenses
Dahkki: Wan Wang, et al.
Almmustuhtton: (2019) -
Biocompatibility and Comfort during Extended Wear of Mel4 Peptide-Coated Antimicrobial Contact Lenses
Dahkki: Parthasarathi Kalaiselvan, et al.
Almmustuhtton: (2022) -
Atorvastatin-Eluting Contact Lenses: Effects of Molecular Imprinting and Sterilization on Drug Loading and Release
Dahkki: Ana F. Pereira-, et al.
Almmustuhtton: (2021) -
Controlled Release of rAAV Vectors from APMA-Functionalized Contact Lenses for Corneal Gene Therapy
Dahkki: Fernando Alvarez-Rivera, et al.
Almmustuhtton: (2020)